NCT04228432View on ClinicalTrials.gov

E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.

NACompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

February 28, 2020

Primary Completion Date

July 21, 2021

Study Completion Date

July 21, 2021

Conditions
Breast Cancer
Interventions
OTHER

Dedicated and coordinated monitoring

"* Coordinated monitoring performed by a dedicated nurse: consultation before hormonotherapy initiation~* Monitoring at home over a period of 6 months using an e-monitoring tool: assessment of adverse events and completion of GIRERD questionnaire at week 3 and week 6."

Trial Locations (1)

Unknown

Institut Universitaire du Cancer Toulouse Oncopole, Toulouse

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT04228432 - E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer. | Biotech Hunter | Biotech Hunter